Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1681087 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $28.43Day −4.60%Mkt cap $536M1Y +27.4%Off 52W high −28.1%Vol (1Y) 82.4%
Daily closing price, split-adjusted to the current basis; 2.1y shown of 524 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.3% of sh out |
| Days to cover7.6d |
| 13F net flow (QoQ)−9.07% |
| Top-10 13F concentration69.0% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$83.5M |
| ROE−37.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+36.3% |
| 1Y+27.4% |
| Since incept. (ann.)+318.7% |
Total return through 2026-07-29 · series begins 2024-06-21. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)82.4% |
| Ann. volatility (3Y)737.7% |
| Sharpe (1Y)0.70 |
| Sharpe (3Y)0.80 |
| Max drawdown (1Y)−44.6% |
| Max drawdown (3Y)−73.2% |
| Beta (3Y vs SPY)0.34 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 2.8M | $87M | 14.93% | +0.3% |
| TCG Crossover Management, LLC | 1.2M | $37M | 6.39% | new |
| Aberdeen Group plc | 1.1M | $35M | 6.05% | +0.0% |
| BlackRock, Inc. | 860,352 | $27M | 4.56% | +0.7% |
| BRAIDWELL LP | 847,151 | $26M | 4.49% | −8.7% |
| First Light Asset Management, LLC | 647,743 | $20M | 3.43% | new |
| BAKER BROS. ADVISORS LP | 607,788 | $19M | 3.22% | −32.7% |
| 5AM Venture Management, LLC | 606,660 | $19M | 3.22% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$1.34 | — | — | — |
| 2025-09-30 | 2025-11-06 | −$1.02 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$1.07 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$0.93 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
